Skip to main content
. Author manuscript; available in PMC: 2014 Apr 1.
Published in final edited form as: Eur Neuropsychopharmacol. 2012 Jun 26;23(4):276–284. doi: 10.1016/j.euroneuro.2012.05.009

Figure 1. Study Design.

Figure 1

Medication-free patients with primary diagnosis of generalized anxiety disorder (GAD) were treated with riluzole 50mg twice a day for 8 weeks. Healthy controls and GAD participants received magnetic resonance imaging and spectroscopy at baseline and at the end of week 8.